Pacific Biosciences
PACB
$8.35
Share price
-0.12%
Change (1 day)
60.27%
Change (1 year)
Categories
Pacific Biosciences (PACB) - P/B ratio
P/B ratio as of October 2023 : 3.26
According to Pacific Biosciences
's latest financial reports the company has a price-to-book ratio of 3.26.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Pacific Biosciences - P/B ratio (from 2010 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 3.29 | -42.42% |
| 2021-12-31 | 5.71 | -60.58% |
| 2020-12-31 | 14.5 | 1.01% |
| 2019-12-31 | 14.3 | 47.03% |
| 2018-12-31 | 9.75 | 173.47% |
| 2017-12-31 | 3.56 | -14.28% |
| 2016-12-31 | 4.16 | -70.88% |
| 2015-12-31 | 14.3 | 35.39% |
| 2014-12-31 | 10.5 | 110.52% |
| 2013-12-31 | 5.01 | 473.94% |
| 2012-12-31 | 0.8730 | 8.91% |
| 2011-12-31 | 0.8016 | -73.32% |
| 2010-12-31 | 3.00 | |
| 2009-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | 4.42 | 35.50% | 🇺🇸 USA |
 General Electric GE | 3.78 | 15.78% | 🇺🇸 USA |
 Illumina ILMN | 3.20 | -2.04% | 🇺🇸 USA |
 PerkinElmer
PKI | 1.80 | -44.85% | 🇺🇸 USA |
 NanoString Technologies NSTG | -4.21 | -229.01% | 🇺🇸 USA |